Cord Blood Collection: confessions of a vampire-midwife

Photo: Archie Rigney and his mother Azure – effective placental transfusion results in an empty, white umbilical cord
**If you like information in an engaging movie format, check out my Early Integration Phase Lesson Package, which includes the newborn transition to breathing and the importance of blood volume**
When I was a bright-eyed and bushy-tailed student midwife, I was awarded a certificate and a box of chocolates. My achievement was collecting the most 'cord' blood in the hospital. At that time, the Local Health District was trialling a 'cord' blood bank. The collected blood was to be used for treating leukaemia and for research. Every woman birthing in the hospital was asked to donate 'cord' blood for the good cause, and many generously agreed. I was exceptionally good at collecting the blood. This post is a small attempt to repent for my sins now that I know better.
'Cord' blood is baby's blood
The term 'cord blood' is misleading. The blood collected via the umbilical cord is the baby's blood. When adults donate blood, it is collected via their arm. We don't refer to that blood as 'arm blood'.
During pregnancy, the baby and placenta share the baby's circulating blood. The placenta provides an extension of the baby's circulation. This allows the baby to receive nutrients and oxygen from the intervillous space between the (separate) mother's circulation and the placenta. After birth, the placental circulation alters, sending all the baby's blood into their body. You can read more about the 'physiology of newborn transition' in this post and more about transfusion by the placenta in this movie:
Knowledge about the short-term and long-term health benefits of the baby having their full blood volume at birth is now widespread (see this post for details).
The importance of stem cells for the baby
Stem cells can self-renew (make copies of themselves) and differentiate (develop into more specialised cells). At birth, babies have haematopoietic stem cells in their blood. This type of stem cell is similar to those found in bone marrow and can regenerate red blood cells and immune system cells. These stem cells likely play an important role in repairing any damage done during birth and may also play a role in longer-term protection from disease.
The business of collecting babies' blood
Companies are targeting parents and making big money by removing and storing their baby's blood. Care providers also make money from recruiting parents and collecting blood for these companies. The sales pitch is: if your baby develops a particular type of illness in the future, you may be able to use their stored stem cells as treatment. These companies are increasingly sponsoring care provider organisations and events, and buying endorsements from obstetricians and midwives. I have even been approached to endorse their services several times—clearly, they had not read this post.
My primary concern with cord blood banking is the misleading information given to parents, which raises ethical and legal issues. Two main areas require further clarification: blood collection volumes, cord clamping, and the effectiveness of stem cell treatments.
Blood collection volumes and cord clamping
Parents need to be informed that collecting blood from the umbilical cord requires premature cord clamping and that the blood being collected belongs in the baby's body.
Paediatric guidelines state that 'blood draws in infants and children should not exceed 5% of the total blood volume in any 24-hour period' [1]. A 3.6kg newborn has a blood volume of around 280mls, so the maximum blood draw is 14mls.
A collection bag holds a significant proportion of the baby's blood. The collection bags for 'cord' blood hold 250mls (35mls already taken up with anticoagulant fluid). The minimum amount of blood acceptable for collection is 45mls, and the maximum possible is 215mls. One procedure guide states, "collect as much cord blood as possible [in bold]." Another company reports that the median volume they collect is 60mls. I wonder how many parents would consent to someone coming onto the postnatal ward and sticking a needle into their baby to collect six adult vials of blood? Cord blood collection is the equivalent of this; only the needle is in the umbilical cord, not the baby.
In response to publicity about the importance of 'delayed' cord clamping, aka 'optimal' cord clamping. The latest marketing ploy is to tell parents they can have both 'delayed' cord clamping and collect 'cord' blood. Some websites even include a page on 'delayed' cord clamping benefits. They define 'delayed' as 30 seconds to 1 minute. However, it usually takes longer than this for the full blood volume to transfer. If all the baby's blood has transferred into the baby – however long that takes for that individual baby – then there is minimal, if any, blood left to collect. Look at the picture at the top of this post. If you can get blood out of that cord you deserve a certificate and chocolates! At least one website acknowledges this, and states that the risk of 'delayed' cord clamping is "reducing the volume of a cord blood collection such that it cannot be banked...". Note that public cord banks require even larger volumes of blood than private.
In contrast, one company refers specifically to 'optimal' cord clamping, i.e., waiting until the cord is white. They suggest that their company can effectively process 10-20mls of 'cord blood'. I have requested evidence of that claim, e.g., photos or a movie of the collection from a white cord, and further information about the effectiveness of a small sample (most other companies state that effective processing for storage is determined by the size of the sample). I am still waiting.
In the meantime, a baby blood company amended its promotion blog after the BBC criticized it for making misleading claims [2].
The effectiveness of stem cell treatments
Parents need to be informed that there is no evidence that cord blood is useful for treating their baby in the future.
There is currently no research evidence demonstrating the effectiveness of 'cord' blood stem cells (haematopoietic) in treating disease or disability. Many company websites hint at this by using the terms 'potential' or 'may' or 'future' or 'hope to'. Sites also claim that 'cord' blood stem cells are being used to treat '80 diseases', with no mention of whether those treatments are effective or not. Some sites refer to the treatments as 'alternative', i.e., they are not being used in mainstream medicine. However, others include claims of successful treatment, citing case studies or anecdotal news articles (often about stem cells in general rather than 'cord' blood specifically). In addition, all of the research (I can find) is being conducted on 'public' stem cells, i.e., those used to treat strangers rather than the baby who donated or their family.
I was recently in correspondence with a representative of a cord blood company and asked for some research evidence to support his claims of successful treatments. He sent me a collection of unreferenced statements (marketing) on the company website and two feasibility studies. Feasibility studies are carried out to demonstrate that a treatment is 'safe', and a study is possible. They do not test the effectiveness of a treatment. I pointed this out and have not heard back. While several trials may be underway with 'public' donations, I have yet to see any actual results relating to 'cord' blood stem cells and treatments. Send me any you may have (research articles only please).
In 2004, The European Commission released a press statement about this situation stating [3]:
If commercial cord blood banks are allowed, appropriate information should be given to the consumers willing to use their services, including the fact that the likelihood that the sample may be used to treat one's child is currently negligible, that the future therapeutic possibilities are of a very hypothetical nature and that up until now there is no indication that the present research will lead to specific therapeutic application of one's own cord blood cells. Therefore, information has to be particularly explicit that the auto conservation has little value in the current state of scientific knowledge. This information should be made clear on all media, including Internet, and in any contracts linking commercial banks to their customers.
Twenty years later, the British Medical Journal published an article raising concern over the claims made for stem cell applications [4]. So, for twenty years, companies have profited from collecting and storing babies' blood without evidence that it will be useful.
Companies have also started offering umbilical cord tissue collection as an alternative to or in addition to cord blood collection. Umbilical cord tissue contains mesenchymal stem cells and can be collected alongside optimal cord clamping. However, there is no evidence that this type of stem cell offers effective treatments.
Summary
I am not suggesting that baby blood banking should not be an available option. I am suggesting that parents need adequate information before they decide to remove a significant amount of their baby's blood volume. They need to weigh the known benefits of full blood volume at birth against an unlikely treatment for an unlikely future illness. Cord blood is babies' blood. Parents must also know if their care provider will benefit financially from persuading them to collect and bank blood.
PS: I no longer participate in stealing babies' blood. We live and learn.
Further resources
You can find more information on this topic in my Early Integration Phase Lesson Package or Reclaiming Childbirth Collective.
Related blog posts
- The Placenta: essential resuscitation equipment
- Active Management of the Placenta
- Information Sharing and the Law
Related podcast episode
References
- Greene (2023) How much blood is too much
- BBC – Cells4Life admits cord blood stem cell promotion 'error'
- EU Press Release – The European Group on Ethics makes public its opinion on the ethical aspects of umbilical cord blood banking
- BMJ (2024) Cord blood banking: experts raise concern over claim made for stem cell applications
Join my mailing list to receive a monthly newsletter containing updates, evidence-based information, musings, rants and other goodies.
You will be sent a confirmation email. If you don't see an email from me in your inbox, check your junk folder and mark my email as 'not spam'.
We hate SPAM. We will never sell your information, for any reason.